Table 4.
Patients with manifest cardiovascular diseases
| Complex intervention A n = 327 | Simple intervention B n = 279 | A vs. B | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean FU | 95% CI | Mean FU | 95% CI | Difference/Odds ratio | 95% CI | p | ICC | p | |
| RR systolic [mmHg] | 134.3 | 132.5-136.1 | 133.8 | 131.8-135.7 | Δ = 0.5 | -2.2-3.2 | 0.698 | 0.033 | 0.080 |
| RR diastolic [mmHg] | 78.1 | 77.0-79.2 | 79.1 | 77.9-80.2 | Δ = -1.0 | -2.5-0.6 | 0.243 | 0.048 | 0.020 |
| Control rate RR < 140/90 | 59.2% | 52.7%-65.7% | 56.9% | 49.9%-63.8% | OR = 1.11 | 0.73-1.70 | 0.632 | 0.076 | 0.015 |
| Control rate RR < 160/95 | 90.2% | 86.4%-93.9% | 88.9% | 84.7%-93.1% | OR = 1.15 | 0.66-1.99 | 0.623 | 0.037 | 0.280 |
| Cholesterol [mg/dl] | 197.8 | 194.1-201.6 | 199.8 | 195.8-203.9 | Δ = -2.0 | -7.6-3.6 | 0.482 | 0.000 | 1.000 |
| Current smoker | 15.2% | 11.2%-19.1% | 19.2% | 15.1%-23.2% | OR = 0.57 | 0.26-1.26 | 0.163 | 0.258 | 0.005 |
| ASS | 73.0% | 69.2%-76.7% | 73.3% | 69.3%-77.2% | OR = 0.96 | 0.46-2.01 | 0.917 | 0.230 | <0.001 |
| Statins | 64.1% | 57.2%-71.0% | 48.2% | 39.7%-56.7% | OR = 2.64 | 1.35-5.16 | 0.005 | 0.280 | <0.001 |
Outcomes at follow up in subpopulation at high CVR (10-year mortality ≥ 5%), but no manifest CVD (complete cases), adjusted for baseline and taking cluster effects into account by use of a mixed model.